Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: An interim analysis

被引：1
|
作者：
Takahara, Naminatsu
Isayama, Hiroyuki
Nakai, Yousuke
Sasaki, Takashi
Ishigami, Hironori
Yamaguchi, Hironori
Kogure, Hirofumi
Yamamoto, Natsuyo
Hirano, Naoki Sasahira Kenji
Tada, Minoru
Kitayama, Joji
Watanabe, Toshiaki
Koike, Kazuhiko
机构：
[1] Kanto Cent Hosp, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Univ Tokyo, Dept Outpatient Chemotherapy, Tokyo, Japan
[5] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan
[6] Senpo Tokyo Takanawa Hosp, Tokyo, Japan
[7] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan
[8] Univ Tokyo, Fac Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.267
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
267
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with oral S-1 for advanced gastric cancer with macroscopic peritoneal metastasis
    Yamaguchi, Hironori
    Ishigami, Hironori
    Emoto, Shigenobu
    Yamashita, Hiroharu
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
    Yamamoto, Tomohisa
    Fujii, Tsutomu
    Hirano, Satoshi
    Motoi, Fuyuhiko
    Honda, Goro
    Uemura, Kenichiro
    Kitayama, Joji
    Unno, Michiaki
    Kodera, Yasuhiro
    Yamaue, Hiroki
    Shimokawa, Toshio
    Hashimoto, Daisuke
    Yamaki, So
    Yoshitomi, Hideyuki
    Miura, Fumihiko
    Ueno, Hideki
    Sekimoto, Mitsugu
    Satoi, Sohei
    TRIALS, 2022, 23 (01)
  • [43] Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
    Tomohisa Yamamoto
    Tsutomu Fujii
    Satoshi Hirano
    Fuyuhiko Motoi
    Goro Honda
    Kenichiro Uemura
    Joji Kitayama
    Michiaki Unno
    Yasuhiro Kodera
    Hiroki Yamaue
    Toshio Shimokawa
    Daisuke Hashimoto
    So Yamaki
    Hideyuki Yoshitomi
    Fumihiko Miura
    Hideki Ueno
    Mitsugu Sekimoto
    Sohei Satoi
    Trials, 23
  • [44] Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
    Ishigami, Hironori
    Fujiwara, Yoshiyuki
    Fukushima, Ryoji
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Imano, Motohiro
    Imamoto, Haruhiko
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Amagai, Kenji
    Kadowaki, Shigenori
    Miwa, Hiroto
    Yamaguchi, Hironori
    Yamaguchi, Takuhiro
    Miyaji, Tempei
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1922 - +
  • [45] Phase III study comparing intraperitoneal paclitaxel plus S-1/paclitaxel with S-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial
    Fujiwara, Y.
    Ishigami, H.
    Fukushima, R.
    Nashimoto, A.
    Yabusaki, H.
    Imamoto, H.
    Imano, M.
    Kodera, Y.
    Uenosono, Y.
    Amagai, K.
    Kadowaki, S.
    Miwa, H.
    Yamaguchi, H.
    Yamaguchi, T.
    Kitayama, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Phase III study of intraperitoneal paclitaxel plus s-1/paclitaxel compared with s-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial
    Ishigami, Hironori
    Fujiwara, Yoshiyuki
    Fukushima, Ryoji
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Imamoto, Haruhiko
    Imano, Motohiro
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Amagai, Kenji
    Kadowaki, Shigenori
    Miwa, Hiroto
    Yamaguchi, Takuhiro
    Yamaguchi, Hironori
    Watanabe, Toshiaki
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Impact of S-1 in Patients with Gemcitabine-refractory Pancreatic Cancer in Japan
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Kogure, Hirofumi
    Hirano, Kenji
    Tsujino, Takeshi
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (08) : 774 - 780
  • [48] Long-Term Survival of a Patient With Pancreatic Ductal Adenocarcinoma With Peritoneal Dissemination Treated With S-1 Plus Intravenous and Intraperitoneal Paclitaxel Followed by Conversion Surgery
    Kotsuka, Masaya
    Satoi, Sohei
    Yanagimoto, Hiroaki
    Yamamoto, Tomohisa
    Kosaka, Hisashi
    Hirooka, Satoshi
    Yamaki, So
    Michiura, Taku
    Inoue, Kentaro
    Matsui, Yoichi
    PANCREAS, 2020, 49 (06) : 857 - 857
  • [49] Intraperitoneal infusion of paclitaxel with S-1 for peritoneal metastasis of advanced gastric cancer : phase I study
    Kurita, Nobuhiro
    Shimada, Mitsuo
    Iwata, Takashi
    Nishioka, Masanori
    Morimoto, Shinya
    Yoshikawa, Kozo
    Higashijima, Jun
    Miyatani, Tomohiko
    Nakao, Toshihiro
    JOURNAL OF MEDICAL INVESTIGATION, 2011, 58 (1-2): : 134 - 139
  • [50] Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
    Shi, Min
    Yang, Zhongyin
    Lu, Sheng
    Liu, Wentao
    Ni, Zhentian
    Yao, Xuexin
    Hua, Zichen
    Feng, Runhua
    Zheng, Yanan
    Wang, Zhenqiang
    Sah, Birendra Kumar
    Chen, Mingmin
    Zhu, Zhenglun
    He, Changyu
    Li, Chen
    Zhang, Jun
    Yan, Chao
    Yan, Min
    Zhu, Zhenggang
    BMC CANCER, 2021, 21 (01)
12345